Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: A dynamic view
- 28 February 1999
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 116 (2), 378-386
- https://doi.org/10.1016/s0016-5085(99)70135-6
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Relationship between biochemical, virological, and histological response during interferon treatment of chronic hepatitis CHepatology, 1997
- Natural history of liver fibrosis progression in patients with chronic hepatitis CThe Lancet, 1997
- Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and DurationHepatology, 1996
- Long-term decrease in serum N-terminal propeptide of type III procollagen in patients with chronic hepatitis C treated with interferon alfaHepatology, 1995
- Clinical Outcomes after Transfusion-Associated Hepatitis CNew England Journal of Medicine, 1995
- A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1995
- Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alphaJournal of Hepatology, 1995
- Interferon-α2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluationHepatology, 1993
- Interferon for non-A, non-B chronic hepatitis: A meta-analysis of randomised clinical trialsJournal of Hepatology, 1991
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991